American Journal of Clinical Dermatology

Article	Citations
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review	280
Alcohol and Smoking Cessation as Potential Modulators for Smoking-Associated Psoriasis Risk in Postmenopausal Women: The Women’s Health Initiative	187
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments	125
Prognostic Biomarkers in Evolving Melanoma Immunotherapy	104
Role of Inflammation and Cytokine Dysregulation in Depression in Patients with Inflammatory Skin Conditions	103
The Current State of Systemic Therapy of Metastatic Uveal Melanoma	94
Disease Duration in Patients Recruited to Psoriasis Phase III Trials: A Systematic Review	87
The Burden of Pediatric Psoriasis: A Systematic Review	77
Predicting the Time to Relapse Following Withdrawal from Different Biologics in Patients with Psoriasis who Responded to Therapy: A 12-Year Multicenter Cohort Study	75
Performance of Staging Systems for Non-head and Neck Cutaneous Squamous Cell Carcinoma	74
Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study	73
Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know	70
Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials	70
Deciphering the Etiologies of Adult Erythroderma: An Updated Guide to Presentations, Diagnostic Tools, Pathophysiologies, and Treatments	70
Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review	65
Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data	65
Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology	64
Agreement Between Nail Psoriasis Severity Index Scores by a Convolutional Neural Network and Dermatologists: A Retrospective Study at an Academic New York City Institution	64
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroi	61
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks	59
Obesity in Hidradenitis Suppurativa: Are GLP-1 Receptor Agonists the New Frontier?	57
Comment on: “Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?”	54
Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion	53
Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation	53
Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study	51

Skin Cancer in Solid Organ Transplant Recipients: A Review	50
Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD Registry	49
Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment	49
48-Week Real-World Outcomes of Lebrikizumab Treatment for Atopic Dermatitis: Systemic Therapy-Naive Versus -Experienced Patients	48
Disease Modification in Psoriasis: Future Prospects for Long-Term Remission	48
Ethnic Differences of Palmoplantar Pustulosis: A Systematic Review	47
Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives	46
Truncal Acne and Scarring: A Comprehensive Review of Current Medical and Cosmetic Approaches to Treatment and Patient Management	46
Dissecting Cellulitis of the Scalp: Current Insights and Therapeutic Advances	44
A Practice Approach to Acne Fulminans in Adolescents	43
Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!	43
Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment	41
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis	41
Real-World Evidence on Dose Spacing of IL-23 Inhibitors in the Treatment of Psoriasis	39
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment Hist	38
Exposome Risk Factors for Vitiligo: A Systematic Evidence Review	37
Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa	37
Management and Long-Term Outcomes of Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) in Children: A Scoping Review	37
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates	35
Scratching the Surface: A Comprehensive Guide to Understanding and Managing Vulvovaginal Itching	34
The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases	33
A Review of the Etiologies and Key Clinical Features of Secondary Hyperhidrosis	32
Oral Lichen Planus: An Update on Diagnosis and Management	32
Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm	31
The Impact of GLP-1 Receptor Agonists on Hair: Beneficial Effects or Adverse Outcomes?	30
Commentary on “Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology”	30
The Burden of Acne Vulgaris on Health-Related Quality of Life and Psychosocial Well-Being Domains: A Systematic Review	29
Frontal Fibrosing Alopecia: An Update	29
Individualized Neoantigen-Directed Melanoma Therapy	28
Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, Canada	28
Expert Recommendations for the Diagnosis and Management of Chronic Hand Eczema in the United States	28
Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists	28
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History	27
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study	27
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)	27
Advancing Precision Medicine in Inflammatory Skin Disease	26
JAK Inhibitors and Inflammatory Nail Disorders: A Systematic Review of Clinical Outcomes and Therapeutic Potential	26
Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials	26
Autoimmune and Cutaneous Inflammatory Comorbidities in Adult-Onset Morphea in the All of Us Research Program	25
Targeting Inflammation in Acne: Current Treatments and Future Prospects	25
Burden to Partners of People with Psoriasis: Results from the FamilyPso International Study	24
Comment on: “Eyebrow and Eyelash Alopecia: A Clinical Review”	24
Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review	24
Acknowledgement to Referees	24
Acknowledgement to Referees	23
Intravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective Analysis in 81 Patients	23
Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis	22
Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial Results	21
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion	21
Management of Acne in Pregnancy	21

Beyond the Herald Patch: Exploring the Complex Landscape of Pityriasis Rosea	21
Cutaneous Small Vessel Vasculitis: A Practical Guide to Diagnosis and Management	21
Approach to the Atypical Wound	21
Defining Moderate Disease and Progression in Hidradenitis Suppurativa: An Expert Framework to Unlock the Window of Opportunity for Prompt Treatment	20
Exploring Suzetrigine's Role in Dermatologic Surgery: A Novel Nonopioid Analgesic for Postoperative Pain Management	20
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study	20
Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year	20
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations	19
The 25th World Congress of Dermatology, Singapore, 3–8 July, 2023: Research Highlights	19
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2	19
Review of Laser Treatments for Post-Inflammatory Hyperpigmentation in Skin of Color	18
Treatment Strategies for Chronic Pruritus and Eczema/Dermatitis in Older Adults Under the Category of Chronic Eczematous Eruptions of Aging (CEEA)	18
Autoimmune, Autoinflammatory Disease and Cutaneous Malignancy Associations with Hidradenitis Suppurativa: A Cross-Sectional Study	17
Safety of Hydroxychloroquine: What a Dermatologist Should Know	17
Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study	17
Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials	16
Real-World Treatment with Lebrikizumab or Tralokinumab for Atopic Dermatitis: A 60-Week Retrospective Comparative Study	16
Comprehensive and Updated Algorithm of Hidradenitis Suppurativa Management from the Experts	16
An Update on New and Existing Treatments for the Management of Melasma	16
Is There a Place for Biologics in Acne?	16
Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”	15
Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies	15
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study	15
Melanoma Brain Metastases: An Update on the Use of Immune Checkpoint Inhibitors and Molecularly Targeted Agents	15
Treatment of Hyperhidrosis: An Update	14
Real-World Effectiveness, Safety, and Drug Survival of Risankizumab in Adult Patients with Plaque Psoriasis: A 3-Year Multicenter Retrospective Cohort Study	14
Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin	14
Patient Care Outcomes in Hospitalized Patients with Acute Generalized Exanthematous Pustulosis: A Cross-Sectional Database Study	14
Clinical Effectiveness and Safety of Initial Combination Therapy with Corticosteroids and Rituximab in Bullous Pemphigoid: A Retrospective Cohort Study	14
Correction to: Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”	14
Abscopal Effects and Immunomodulation in Skin Cancer Therapy	14
Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies	14
Correction to: Mastocytosis in the Skin: Approach to Diagnosis, Evaluation, and Management in Adult and Pediatric Patients	14
Pharmacokinetics of Roflumilast Cream in Chronic Plaque Psoriasis: Data from Phase I to Phase III Studies	14
Update in Diagnosis and Management of Primary Cutaneous B-Cell Lymphomas	14
Human Inborn Errors of Immunity in Pyoderma Gangrenosum: A Systematic Review	13
The Skin and Gut Microbiome in Hidradenitis Suppurativa: Current Understanding and Future Considerations for Research and Treatment	13
Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials	13
Lichen Planus: What is New in Diagnosis and Treatment?	13
KECORT Study: An International e-Delphi Study on the Treatment of KEloids Using Intralesional CORTicosteroids in Clinical Practice	12
Real-World Experience of Bimekizumab for Plaque Psoriasis in Adult Patients with Prior Exposure to Interleukin-23 Inhibitors: A Multicenter Retrospective Study	12
Factors Associated with Symptomatic Dermographism: Findings from the UCARE PREVALENCE-D Study	12
Management of Coexisting Bullous Pemphigoid and Psoriasis: A Review	12
Atopic Dermatitis Across Shades of Skin	12
Mastering the Use of Systemic JAK Inhibitors for Atopic Dermatitis: A Dermatologist's Practical Guide	12
Meat Allergy: A Ticking Time Bomb	11
Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis	11
Blue Nail Discoloration: Literature Review and Diagnostic Algorithms	11
Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks	11
Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis	11
Bimekizumab Complete Clearance of Both Skin and Nail Psoriasis: Comparative Efficacy in Phase III/IIIb Studies	11
Lichen Simplex Chronicus: Clinical Perspectives and Emerging Therapeutic Strategies	11
Automated Facial Acne Lesion Detecting and Counting Algorithm for Acne Severity Evaluation and Its Utility in Assisting Dermatologists	11
Oral Roflumilast in Patients with Psoriasis: A Real-World Cohort Study	11
Alopecia in Children with Cancer: A Review from Pathophysiology to Management	11
Suggestions for a New Clinical Classification Approach to Panniculitis Based on a Mayo Clinic Experience of 207 Cases	11
Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial	10
Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast	10
Dapsone Use in Dermatology	10
Eyebrow and Eyelash Alopecia: A Clinical Review	10
Cholestatic Itch: Our Current Understanding of Pathophysiology and Treatments	10
Ultrasound Surveillance in Melanoma Management: Bridging Diagnostic Promise with Real-World Adherence: A Systematic Review and Meta-Analysis	10
What’s New in Therapy for Male Androgenetic Alopecia?	9
Management of Erythrodermic Psoriasis with Systemic Therapies: A Systematic Review	9
Alopecia Areata: Current Treatments and New Directions	9
Cellulitis in Pediatric Patients: Recognition and Management in the Era of Evolving Resistance	9
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy	9
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments	9
Correction to: Adherence to Hidradenitis Suppurativa Treatment	9
Beyond the Hot Comb: Updates in Epidemiology, Pathogenesis, and Treatment of Central Centrifugal Cicatricial Alopecia from 2011 to 2021	8
Icotrokinra: An Oral Interleukin-23 Receptor Antagonist Peptide for the Treatment of Psoriasis	8
Adherence to Hidradenitis Suppurativa Treatment	8
Deucravacitinib for the Treatment of Psoriatic Disease	8
Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program	8
Field Cancerization Therapies for the Management of Actinic Keratosis: An Updated Review	8
Comment on: “Methotrexate Cutaneous Ulceration: A Systematic Review of Cases”	7
Psoriasis: Considerations for the Management of Women of Childbearing Potential	7
Radiotherapy-Induced Skin Fibrosis: Pathophysiology, Emerging Therapeutics, and the Role of Dermatology	7
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Cl	7
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis	7

Acute and Chronic Cutaneous Graft-versus-Host Disease: Diagnosis, Treatment, and Emerging Directions	7
Switching from Dupilumab to Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis After Inadequate Response to Dupilumab: Efficacy and Safety Results from Period 2 of Phase	7
Understanding Enthesitis in Psoriatic Disease: Insights and Implications	7
Development and Validation of an Artificial Intelligence-Driven Model for Accurate Classification of Erythrodermic Psoriasis Severity: Erythrodermic Psoriasis Integrated Classification System (EPICS)	7
A Guide to the Management of Hidradenitis Suppurativa in Pregnancy and Lactation	7
Psychological Therapies and Mind–Body Techniques in the Management of Dermatologic Diseases: A Systematic Review	7
Evaluating the Longitudinal Course of Atopic Dermatitis: Implications for Clinical Practice	6
American Academy of Dermatology Annual Meeting: San Diego, CA, USA, 8–12 March 2024	6
Perioperative Systemic Therapy for High-Risk Cutaneous Squamous Cell Carcinoma	6
Relationship of Histopathologic Parameters and Gene Expression Profiling in Malignant Melanoma	6
Maximal Usage Trial of Tapinarof Cream 1% Once Daily in Pediatric Patients Down to 2 Years of Age with Extensive Atopic Dermatitis	6
Stasis Dermatitis: An Overview of Its Clinical Presentation, Pathogenesis, and Management	6
Global Incidence, Mortality, Risk Factors and Trends of Melanoma: A Systematic Analysis of Registries	6
Sequencing of Targeted Therapy in Psoriasis: Does it Matter?	6
Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies	6
Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials	6
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial	6
Development of Cutaneous T-Cell Lymphoma Following Biologic Treatment: A Systematic Review	6
Clinical Efficacy and Safety of Interleukin-17 Inhibitors in Treating Patients with Erythrodermic Psoriasis: A Retrospective Cohort, Three-Center Study	6
Hidradenitis Suppurativa: New Targets and Emerging Treatments	6
Association of Cardiovascular Disease and Chronic Spontaneous Urticaria: A Case–Control Study	6
Publisher Correction to: Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm	6
Nicotinamide for Skin Cancer Chemoprevention: The Jury Was Out and Still is	6
Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial	6